PSI CRO opens fourth new office of the year, growth expected to continue into 2018

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Tuangtong)
(Image: Getty/Tuangtong)

Related tags: Contract research organization

PSI CRO has opened an office in Madrid, Spain marking the company’s fourth new office to open in 2017.

All of our locations and expansions are driven by the clinical trial requests from biotech and pharma sponsors that we work with​,” Kayt Leonard a PSI CRO spokesperson told

Additionally, she said the contract research organization’s (CRO) sites in Spain have demonstrated “a consistent and reliable data delivery​.” Specifically, in the areas of oncology and oncohematology.

Leonard also noted that being in the capital city provides the company with access to various resources.

Moving into 2018, Leonard said PSI will continue to grow, though “plans and locations are all based on where our clients need us to be, combined with where we can best contribute to clinical trials​.”

We’ve grown organically for the past 22 years, and we’ll continue in that manner throughout 2018 and beyond,​” she added.

In September, PSI announced a string of investments in the Asia Pacific region, with a new office in Seoul, South Korea​, as well as Taipei, Taiwan​.

Related news

Related products

show more


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Related suppliers